Dalrada Health and Vivera Pharmaceuticals Announce New Diagnostic Laboratory Joint Venture

SAN DIEGO--(BUSINESS WIRE)---- $DFCO #BrianBonar--To address the ongoing demand for COVID-19 testing and to catalyze safe return of the workforce, Dalrada Corporation (OTCQB: DFCO, “Dalrada”) is excited to announce that its subsidiary, Dalrada Health, entered into a joint venture partnership with Vivera Pharmaceutical, Inc. (“Vivera”) to form Pala Diagnostics, LLC...

Click to view original post